Molecular characterization of HER2-low invasive breast carcinoma by quantitative RT-PCR using Oncotype DX (R)

The oncologist(2023)

引用 0|浏览6
暂无评分
摘要
Cancers with higher mRNA levels exist within IHC 0 and low categories, most of the HER2-low patients by IHC have low RS indicating no benefit from current adjuvant chemotherapies.
更多
查看译文
关键词
oncotype dx assay,carcinoma,molecular characterization,rt-pcr
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要